Efficacy and Tolerability of a Low-Dose Continuous Regimen of Regorafenib in Refractory Synovial Sarcomas: A Single-Arm, Phase II Trial From India All AYA OGS and ES cases treated at our institute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback